全文获取类型
收费全文 | 8726篇 |
免费 | 472篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 85篇 |
儿科学 | 180篇 |
妇产科学 | 120篇 |
基础医学 | 1210篇 |
口腔科学 | 213篇 |
临床医学 | 959篇 |
内科学 | 2063篇 |
皮肤病学 | 222篇 |
神经病学 | 781篇 |
特种医学 | 378篇 |
外科学 | 1288篇 |
综合类 | 75篇 |
一般理论 | 2篇 |
预防医学 | 525篇 |
眼科学 | 82篇 |
药学 | 605篇 |
中国医学 | 7篇 |
肿瘤学 | 444篇 |
出版年
2023年 | 43篇 |
2022年 | 51篇 |
2021年 | 135篇 |
2020年 | 104篇 |
2019年 | 160篇 |
2018年 | 217篇 |
2017年 | 170篇 |
2016年 | 200篇 |
2015年 | 163篇 |
2014年 | 248篇 |
2013年 | 372篇 |
2012年 | 513篇 |
2011年 | 527篇 |
2010年 | 336篇 |
2009年 | 294篇 |
2008年 | 468篇 |
2007年 | 528篇 |
2006年 | 499篇 |
2005年 | 474篇 |
2004年 | 427篇 |
2003年 | 431篇 |
2002年 | 385篇 |
2001年 | 154篇 |
2000年 | 154篇 |
1999年 | 145篇 |
1998年 | 98篇 |
1997年 | 82篇 |
1996年 | 70篇 |
1995年 | 52篇 |
1994年 | 71篇 |
1993年 | 52篇 |
1992年 | 97篇 |
1991年 | 95篇 |
1990年 | 90篇 |
1989年 | 82篇 |
1988年 | 80篇 |
1987年 | 76篇 |
1986年 | 62篇 |
1985年 | 74篇 |
1984年 | 77篇 |
1983年 | 56篇 |
1982年 | 54篇 |
1981年 | 44篇 |
1980年 | 40篇 |
1979年 | 47篇 |
1978年 | 60篇 |
1977年 | 44篇 |
1975年 | 34篇 |
1974年 | 29篇 |
1972年 | 28篇 |
排序方式: 共有9239条查询结果,搜索用时 373 毫秒
1.
Shafqat R. Chaudhry Ilana S. Lendvai Sajjad Muhammad Philipp Westhofen Johannes Kruppenbacher Lukas Scheef Henning Boecker Dirk Scheele Rene Hurlemann Thomas M. Kinfe 《Brain stimulation》2019,12(3):643-651
Objective
To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.Methods
This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.Results
No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p?>?0.05]. No severe device-/stimulation-related adverse events occurred.Conclusion
2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. 相似文献2.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.3.
Willemijn A K M Windt Atsua Tahara Alex C A Kluppel Dick de Zeeuw Robert H Henning Richard P E van Dokkum 《Journal of the renin-angiotensin-aldosterone system》2006,7(4):217-224
INTRODUCTION: Vasopressin, mainly through the V1a-receptor, is thought to be a major player in the maintenance of hyperfiltration. Its inhibition could therefore lead to a decrease in progression of chronic renal failure. To this end, the effect of the vasopressin V1a-receptor-selective antagonist, YM218, was studied on proteinuria and focal glomerulosclerosis in early and late intervention after 5/6 nephrectomy in rats, and compared with an angiotensin-converting enzyme inhibitor (ACE-I). MATERIALS AND METHODS: After 5/6 nephrectomy, early intervention was performed between week 2 and 10 thereafter with the V1a-receptor-selective antagonist (VRA, 10 mg/kg/day, n=10), enalapril (ACE-I, 10 mg/kg/day, n=9), or vehicle (n=8). Late intervention was performed in another group between week 6 and 12 with VRA (10 mg/kg/day, n=7), lisinopril (ACE-I, 5 mg/kg/day, n=7), or vehicle (n=7). RESULTS: In early intervention, proteinuria and focal glomerulosclerosis were significantly decreased by VRA compared to vehicle (44+7% and 59+8% respectively). ACE-I significantly decreased proteinuria (67+7%) and a trend towards a decrease in focal glomerulosclerosis was observed (30+18%). In late intervention, VRA did not decrease proteinuria and focal glomerulosclerosis compared to vehicle (21+20% and 0%, respectively), ACE-I significantly lowered proteinuria (92+2%) and a focal glomerulosclerosis (69+1%) lowering trend was observed. CONCLUSION: These results indicate that VRA may protect against early progression of renal injury after 5/6 nephrectomy, whereas its effectiveness seems limited in established renal damage. 相似文献
4.
5.
6.
Lehnartz N. Henning Katsch E. Grafe Stodtmeister Klose 《Journal of molecular medicine (Berlin, Germany)》1940,19(36):921-922
Ohne Zusammenfassung 相似文献
7.
Ordinary surgical rubber gloves are penetrated by methylmethacrylate monomer (MMA) in less than 1 minute, as demonstrated by gas chromatographic measurements. A three-layered PVP glove, 0.07 mm thick - consisting of an outer layer of polyethylene, an intermediary layer of ethylene vinyl alcohol copolymer, and an inner layer of polyethylene - was impervious for 20 minutes, whereas a viton-butyl rubber glove, 0.27 mm thick, was impervious for 15 minutes.
The PVP glove is recommended to orthopedic surgeons, nurses, and other handling acrylic bone cements to avoid sensitization, and is especially recommended to persons with known contact allergy to MMA. 相似文献
The PVP glove is recommended to orthopedic surgeons, nurses, and other handling acrylic bone cements to avoid sensitization, and is especially recommended to persons with known contact allergy to MMA. 相似文献
8.
9.
10.
Priv.-Doz. Dr. M. Steen 《Trauma und Berufskrankheit》2004,6(2):90-94
Only a small percentage of “minor” hand injuries are treated by surgeons with a specialist training in hand surgery, partly because they are so frequent. In most cases this does not prejudice the outcome. There are, however, still patients whose treatment takes an unexpectedly long time and who are not successfully rehabilited but are left with lasting problems justifying early retirement. To face up to these problems, which are often the result of inadequate or inappropriate treatment, a model hand surgery project established as part of the treatment plan by several of the regional branches of the German employers’ liability insurance associations (Southwest Germany, Berlin, Brandenburg, Mecklenburg-Upper Pomerania, and Northwest Germany) has been in place since spring 2002. This project and the experience recorded in patients treated according to the procedures laid down for it are presented in this paper. 相似文献